Want to see AQB full AI Analyst Report?
AQB Stock Chart & Stats
$0.96
-$0.09(-10.49%)
At close: 4:00 PM EST
$0.96
-$0.09(-10.49%)
Day’s Range― - ―
52-Week Range$0.70 - $2.95
Previous CloseN/A
Volume79.08K
Average Volume (3M)1.58M
Market Cap
$4.94M
Enterprise Value$7.31
Total Cash (Recent Filing)$440.68K
Total Debt (Recent Filing)$3.80M
Price to Earnings (P/E)―
Beta0.69
Next Earnings
Aug 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.13
Shares Outstanding5,147,204
10 Day Avg. Volume221,557
30 Day Avg. Volume1,577,744
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-1.91
Price to Sales (P/S)0.00
P/FCF Ratio>-0.01
Enterprise Value/Market Cap<0.01
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-7.28
Revenue Forecast (FY)$500.00K
Bulls Say, Bears Say
Bulls Say
Proprietary GE Salmon IPAquaBounty's core technology—genetically engineered Atlantic salmon—represents a durable competitive asset. Proprietary genetics and production know‑how can yield structural cost advantages (faster growth, better feed conversion) and create licensing or partnership opportunities beyond direct farming.
Access To Capital Via Private PlacementThe June 2026 preferred stock placement shows the company can tap accredited investors to fund operations. While dilutive, this demonstrates ongoing external funding access that materially extends runway and supports near‑term operations and commercialization efforts versus no financing option.
Shareholder Backing And Governance ContinuityAnnual re‑election of directors and auditor ratification indicate shareholder support and governance continuity. Board authorization for capital‑structure tools (reverse split authority) gives management durable flexibility to address listing or financing needs if required, aiding strategic options.
Bears Say
Persistent Losses And Negative EquityAccumulated losses that pushed equity negative signal structural capital erosion. Negative shareholders' equity reduces financial flexibility, elevates creditor and covenant risk, and constrains the company's ability to invest in scaling operations without continued external support over the coming months.
Very Weak Cash Generation / Cash BurnSustained negative operating and free cash flow indicate the business is consuming capital to sustain operations rather than generating it. This structural cash burn creates recurring liquidity requirements, making the company dependent on external financing and increasing execution risk over a multi‑month horizon.
Inconsistent/near‑zero Revenue And Small ScaleRepeated near‑zero reported revenue demonstrates the firm has not established stable commercial scale. With only three employees and intermittent product sales, the company faces structural hurdles to realize fixed‑cost leverage, build distribution, and achieve predictable margin improvement.
AquaBounty Technologies News
AQB FAQ
What was AquaBounty Technologies Inc’s price range in the past 12 months?
AquaBounty Technologies Inc lowest stock price was $0.70 and its highest was $2.95 in the past 12 months.
What is AquaBounty Technologies Inc’s market cap?
AquaBounty Technologies Inc’s market cap is $4.94M.
When is AquaBounty Technologies Inc’s upcoming earnings report date?
AquaBounty Technologies Inc’s upcoming earnings report date is Aug 11, 2026 which is in 19 days.
How were AquaBounty Technologies Inc’s earnings last quarter?
AquaBounty Technologies Inc released its earnings results on Apr 30, 2026. The company reported -$0.263 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is AquaBounty Technologies Inc overvalued?
According to Wall Street analysts AquaBounty Technologies Inc’s price is currently Overvalued.
Does AquaBounty Technologies Inc pay dividends?
AquaBounty Technologies Inc does not currently pay dividends.
What is AquaBounty Technologies Inc’s EPS estimate?
AquaBounty Technologies Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AquaBounty Technologies Inc have?
AquaBounty Technologies Inc has 5,147,204 shares outstanding.
What happened to AquaBounty Technologies Inc’s price movement after its last earnings report?
AquaBounty Technologies Inc reported an EPS of -$0.263 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.644%.
Which hedge fund is a major shareholder of AquaBounty Technologies Inc?
Currently, no hedge funds are holding shares in AQB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
AquaBounty Technologies Inc
AquaBounty Technologies, Inc. is a biotechnology firm dedicated to boosting productivity within the commercial fish farming sector across the United States and Canada. The company's research initiatives delve into genetics, genomics, fish health, and nutrition. Its flagship offering is AquAdvantage Salmon, a genetically engineered Atlantic salmon intended for human consumption. Beyond this, AquaBounty also supplies conventional Atlantic salmon, along with salmon eggs, juvenile fish (fry), and various byproducts. Established in 1991, the firm maintains its headquarters in Maynard, Massachusetts. It operated under the name Aqua Bounty Farms, Inc. until its rebranding in June 2004.
Technical Analysis
Ownership Overview
―
Insiders
1.30% Mutual Funds
1.73% Other Institutional Investors
96.52% Public Companies and
Individual Investors